Search

Pulse Biosciences Inc

Chiusa

SettoreSettore sanitario

47.86 -3.93

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

47.79

Massimo

50.1

Metriche Chiave

By Trading Economics

Entrata

-6.1M

-25M

Vendite

33K

434K

EPS

-0.36

Margine di Profitto

-5,681.336

Dipendenti

116

EBITDA

-5.8M

-25M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+8.37% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.1B

3.7B

Apertura precedente

51.79

Chiusura precedente

47.86

Notizie sul Sentiment di mercato

By Acuity

50%

50%

87 / 340 Classifica in Healthcare

Pulse Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 ott 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1 ott 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30 set 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29 set 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28 set 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25 set 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24 set 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23 set 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22 set 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21 set 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18 set 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17 set 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 set 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 set 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 set 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 set 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 set 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 set 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

8 set 2026, 23:31 UTC

Pulse Biosciences Inc shares are higher in after-market trading, recovering significantly and nearing the upper end of their one-month range.

4 set 2026, 22:26 UTC

Pulse Biosciences Inc. shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

3 set 2026, 22:21 UTC

Pulse Biosciences Inc shares are lower in after-market hours amid notable volatility, reversing gains from the previous four sessions without specific news to explain the decline.

2 set 2026, 23:41 UTC

Pulse Biosciences Inc shares are higher in after-market hours, recovering from earlier losses amid broader market strength following weaker job growth data from ADP.

1 set 2026, 22:51 UTC

Pulse Biosciences Inc shares are higher in after-market trading, following earlier volatility amid macroeconomic pressures and a mixed sentiment in the health care equipment sector.

31 ago 2026, 20:07 UTC

Pulse Biosciences is trading higher, reflecting broader market gains since Friday. The stock remains above its 20-day moving average and near its one-month range.

29 ago 2026, 00:01 UTC

Pulse Biosciences Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the top of its one-month range.

28 ago 2026, 23:46 UTC

Pulse Biosciences Inc is trading lower in after-market hours, with no specific news identified to explain the movement. Broader market conditions may be influencing sentiment.

27 ago 2026, 20:07 UTC

News

Pulse Biosciences Inc. is higher today, recovering from a prior session decline. Analyst Mike Matson has a Buy rating and $58 price target.

26 ago 2026, 23:21 UTC

Pulse Biosciences Inc is higher in after-market trading, reflecting a broader market trend. The price remains near the upper end of its one-month range.

25 ago 2026, 20:07 UTC

Shares of Pulse Biosciences Inc. are lower today, reflecting routine volatility amid a broader market backdrop of declining oil prices and Treasury yields.

24 ago 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

Confronto tra pari

Modifica del prezzo

Pulse Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

8.37% in crescita

Previsioni per 12 mesi

Media 54 USD  8.37%

Alto 73 USD

Basso 35 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pulse Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

6

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

87 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.